.png)
The $5,000 Experiment: How GrowthTech.ai's Top 5 Stocks and Top 5 Crypto Picks Turned $10,000 Into $46,434 in One Year
- GrowthTech.ai
- 5 hours ago
- 11 min read
Tracking Period: May 22, 2025 – May 22, 2026 Top 5 Stocks Average Return: 537.59% Top 5 Crypto Average Return: 191.09%
While the rest of the market was guessing, GrowthTech.ai's BullsEye system was ranking.
Twelve months ago, on May 22, 2025, you could have split $10,000 evenly between two GrowthTech.ai watchlists — five stocks and five crypto assets, equal weight, no leverage, no rotation.
Today, that $10,000 is worth $46,434.
The stock half — $5,000 spread across five tickers — compounded into $31,879.69. The crypto half — $5,000 across five digital assets — compounded into $14,554.40.
No active management. No options. No insider trading. Just the ten names the AI ranked and the willingness to follow the system.
This article walks through every single pick — what it was, what catalysts drove the move, and why the BullsEye Market Intelligence System surfaced it before the broader market caught on.
The Stock Portfolio: 5 Names, +537.59% Average
# | Ticker | Company | 1-Year Return |
1 | CELC | Celcuity Inc. | +1,216.48% |
2 | MU | Micron Technology | +689.03% |
3 | IREN | IREN Limited | +502.65% |
4 | ACMR | ACM Research | +216.44% |
5 | TWLO | Twilio Inc. | +63.37% |
$5,000 evenly split across these five picks → $31,879.69 today.
1. Celcuity Inc. (NASDAQ: CELC) — +1,216.48%
Celcuity is a clinical-stage biotechnology company developing gedatolisib, a pan-PI3K/mTOR inhibitor targeting HR+/HER2- advanced breast cancer.
A year ago, Celcuity was a relatively obscure Minneapolis-based biotech awaiting late-stage data. Twelve months later, it has become one of oncology's most-watched names — and one of the highest-returning small-caps on the Nasdaq.
The catalysts that justified the move:
Positive Phase 3 VIKTORIA-1 results in the PIK3CA wild-type cohort, demonstrating statistically significant and clinically meaningful improvement in progression-free survival
FDA acceptance of the gedatolisib NDA with Priority Review and a confirmed PDUFA action date of July 17, 2026
Positive topline results in the PIK3CA-mutant cohort announced May 1, 2026 — full data scheduled for late-breaking presentation at the 2026 ASCO Annual Meeting (May 29–June 2, 2026)
Expansion of the Phase 3 VIKTORIA-2 trial to evaluate gedatolisib as first-line treatment in endocrine-sensitive HR+/HER2- advanced breast cancer
Q1 2026 corporate update confirming the company is on track to launch gedatolisib commercially pending FDA approval in Q3 2026
Board strengthening with the addition of seasoned oncology commercialization executive Vince Romp
This is exactly the asymmetric biotech setup the BullsEye system is built to find: a single lead asset with multiple shots on goal, an upcoming regulatory decision, and institutional positioning ahead of the catalyst.
2. Micron Technology, Inc. (NASDAQ: MU) — +689.03%
Micron is the third of the world's three vertically integrated memory manufacturers — and during the tracking period, it became the most leveraged pure-play on the AI memory bottleneck.
Memory was supposed to be a cyclical business. The AI buildout broke that pattern.
The catalysts that justified the move:
High-Bandwidth Memory (HBM) for 2026 fully sold out under binding customer contracts — granting Micron unprecedented pricing power and revenue visibility
Q1 FY2026 results: revenue of $13.64 billion (up 57% year over year), non-GAAP EPS of $4.78 versus the $3.94 consensus, GAAP gross margin expanding to 56% from 38% a year earlier
Q2 FY2026 guidance of $18.7 billion in revenue at 68% gross margins
Cloud Memory revenue of $5.3 billion at roughly 66% margin, with Data Center revenue of $2.4 billion at approximately 51% margin
Design wins locked in with NVIDIA and AMD for HBM3e, with HBM4 supply already pre-sold
Wall Street price targets re-rated dramatically higher, with Wedbush and other firms raising targets to $500 and beyond as Micron transitioned from a "cyclical hardware" narrative to a "non-substitutable AI bottleneck"
GrowthTech.ai surfaced MU not because it was the obvious AI name, but because the AI flagged the early margin inflection — long before the price targets caught up.
3. IREN Limited (NASDAQ: IREN) — +502.65%
IREN began the tracking period as a Bitcoin miner. It ended it as one of the most credible AI cloud infrastructure plays on the market.
This was a pivot story. The market just took twelve months to fully price it in.
The catalysts that justified the move:
$9.7 billion multi-year cloud infrastructure agreement with Microsoft (November 2025) to deliver GPU cloud capacity powered by NVIDIA GB300 GPUs at IREN's Childress, Texas data center
$5.8 billion purchase agreement with Dell Technologies for GPUs and related compute hardware tied to the Microsoft deal
$3.4 billion, five-year AI cloud contract with NVIDIA, signed in IREN's third fiscal quarter of 2026
NVIDIA strategic partnership announced in May 2026 to deploy up to 5 gigawatts of Nvidia DSX-branded data center infrastructure
AI cloud services revenue up 94.2% sequentially to $33.6 million in Q3 FY2026, at an 86.3% gross margin
$3.1 billion in annual recurring revenue under contract at quarter-end, with a $3.7 billion ARR target by end of calendar 2026
1.4-GW Sweetwater 1 facility in Texas becoming operational in April 2026
$3.0 billion convertible senior notes offering closed in May 2026 to fund continued GPU and infrastructure buildout
Acquisition of cloud infrastructure provider Mirantis for $625 million in stock to broaden the full-stack AI offering
The BullsEye system flagged IREN before the consensus relabeled it from "Bitcoin miner" to "AI infrastructure." That relabeling is precisely the kind of perception gap GrowthTech.ai's market intelligence engine is engineered to exploit.
4. ACM Research, Inc. (NASDAQ: ACMR) — +216.44%
ACM Research designs and manufactures wafer processing equipment — cleaning, electroplating, polishing, and packaging tools — for the world's leading semiconductor foundries. It is the only U.S.-listed pure-play exposed to the buildout of China's advanced chip manufacturing capacity.
The catalysts that justified the move:
Q1 2026 revenue of $231.3 million, up 34.2% year over year, with EPS of $0.34 versus a $0.28 consensus (a 21.4% beat)
2026 revenue guidance reaffirmed at $1.08 billion to $1.175 billion, implying 20–30% full-year growth
Preliminary shipment growth of 49–52% year over year for Q1 2026
Launch of the "ACM Planetary Family" at SEMICON China 2026 — a unified eight-product portfolio aligned to every key step in advanced semiconductor manufacturing
Sale of approximately 4.8 million ACM Shanghai shares in February 2026, generating roughly $110 million in gross proceeds (~$86 million net) to fund U.S. and global expansion
Proposed Hong Kong Stock Exchange H-share listing for ACM Shanghai announced April 2026
Cash, restricted cash, and time deposits reaching approximately $1.25 billion — a fortress balance sheet for continued expansion
Margin pressure noted in the quarter, but execution and the AI-driven demand backdrop offset the noise
ACMR is the kind of name retail investors almost never find. The BullsEye system did.
5. Twilio Inc. (NYSE: TWLO) — +63.37%
Twilio was the value-tilted reset story in the portfolio. Where the other four picks were aggressive growth setups, TWLO was an earnings-and-margin recovery being repriced as AI infrastructure.
The catalysts that justified the move:
Q1 2026 results: revenue of $1.41 billion, up 20% reported (16% organic) — the strongest growth in more than three years
GAAP income from operations of $107.7 million, up 366% year over year
Non-GAAP income from operations of $278.9 million, up 31%
2026 revenue growth guidance raised to 14–15%, with adjusted operating income guidance of $1.08–$1.10 billion
Q2 2026 guidance set above consensus at revenue of $1.42–$1.43 billion and EPS of $1.27–$1.32
Named a Leader in the 2026 IDC MarketScape and 2026 Omdia Universe for engagement platforms — independent third-party validation of Twilio's positioning as foundational AI customer engagement infrastructure
Bank of America upgrade to Buy with a price target raised from $110 to $190
Doug Robinson (former Co-President of Workday) appointed to the Board of Directors in March 2026, signaling renewed go-to-market discipline
CEO Khozema Shipchandler called Q1 2026 "a milestone quarter" and stated the company had become "a foundational infrastructure layer in the era of AI." The market agreed.
The Crypto Portfolio: 5 Assets, +191.09% Average
Digital assets are a different game. They move faster, drawdown harder, and reward systematic ranking even more than equities do.
# | Asset | Name | 1-Year Return |
1 | ZEC | Zcash | +790.33% |
2 | HYPE | Hyperliquid | +69.70% |
3 | CC | CyberCoin | +61.50% |
4 | TRX | TRON | +35.32% |
5 | XMR | Monero | −1.41% |
$5,000 evenly split across these five picks → $14,554.40 today.
Even with one losing position (XMR) and one modest gainer (TRX), the portfolio still nearly tripled. That is the power of asymmetric weighting and ranking discipline — you do not need every pick to win.
1. Zcash (ZEC) — +790.33%
The privacy coin story of the cycle. Zcash spent years in the wilderness, trading at fractions of its 2017 all-time high. Then, in a matter of weeks, it became one of the most talked-about assets in crypto.
The catalysts that justified the move:
Naval Ravikant's October 2025 endorsement on X: "Bitcoin is insurance against fiat. Zcash is insurance against Bitcoin." ZEC ran from roughly $53 to over $230 in the weeks that followed
Multicoin Capital disclosed accumulation since February 2026, with co-founder Tushar Jain publicly outlining the privacy thesis
Grayscale spot ZEC ETF filing — the first institutional product structure for the asset
Shielded supply hit a record ~30% of circulating ZEC, providing structural float reduction
EU AMLR (Anti-Money Laundering Regulation) moving toward a 2027 privacy-coin ban accelerated demand from holders seeking pre-restriction accumulation
Trading volume surged over 1,000% at the peak of the rally, with cross-chain integrations via THORSwap extending utility
A geopolitical risk-off environment combined with AI-driven financial surveillance concerns added a structural tailwind
GrowthTech.ai's crypto ranking flagged ZEC well before the consensus rediscovered the privacy narrative. Subscribers were positioned before Naval's post — not after.
2. Hyperliquid (HYPE) — +69.70%
Hyperliquid is the decentralized perpetuals exchange that quietly began clearing more volume than most centralized venues. HYPE is its native token.
The catalysts that justified the move:
HYPE crossed $45 in May 2026, with the token's market capitalization reaching approximately $10.84 billion and ranking as a top-15 crypto asset
S&P Dow Jones Indices licensed the S&P 500 to Trade[XYZ] for a perpetual contract running on Hyperliquid (March 2026) — bringing real-world index derivatives on-chain
Grayscale HYPE ETF filing (proposed Nasdaq ticker GHYP) in March 2026
Bitwise added HYPE to its balance sheet using fees from its Hyperliquid ETF product
SpaceX pre-IPO perpetual contract launched on Hyperliquid via Trade.xyz, sparking a 7% single-day rally
97% of protocol fees directed to HYPE token buybacks — a structural flywheel that reduces float as platform volume grows
Arthur Hayes (BitMEX co-founder) publicly disclosed that his Maelstrom family office had made HYPE its largest liquid altcoin position, publishing a thesis titled Valhalla
AQAv2 upgrade in partnership with Coinbase and Circle bringing USDC liquidity into the Hyperliquid ecosystem
The BullsEye ranking caught HYPE early in its institutional repricing — before the ETF filings, before the index licensing, before the Bitwise treasury allocation.
3. CyberCoin (CC) — +61.50%
A smaller-cap digital asset that delivered steady, disciplined appreciation across the tracking window. The asset benefited from the broader rotation into mid-cap crypto names as Bitcoin dominance compressed and capital flowed down the risk curve in late 2025 and into 2026.
This is precisely the type of secondary position that quietly compounds in a ranked portfolio — not the headline winner, but the kind of pick that turns an above-average year into an exceptional one.
The BullsEye system does not need every pick to be a moonshot. It needs the average across the basket to outperform, and lower-volatility 60%+ moves like CC are exactly how that gets done.
4. TRON (TRX) — +35.32%
TRON anchored the crypto portfolio with what might be called the "boring stablecoin infrastructure" trade. While other assets in the basket were running 700%+, TRX quietly delivered a 35% return on the back of structurally accelerating real-world usage.
The catalysts that justified the move:
USDT on TRON surpassed $86 billion in circulation — approximately half of Tether's total supply and roughly 75% of all USDT transfers globally
Over 14 billion total transactions processed, with a Q1 2026 record of 10.9 million average daily transactions
Canary Staked TRX ETF filed amended S-1 with the SEC on May 15, 2026; T-Rex Group separately filed for a 2x leveraged TRX ETF — both signaling serious institutional interest
SEC case resolution in March 2026: a final judgment ordered Rainberry to pay a $10 million civil penalty while the broader claims against Justin Sun, the TRON Foundation, and BitTorrent were dismissed — removing a multi-year overhang
Binance.US relisting of TRX in April 2026, restoring U.S. market access
Gas Abstraction rollout allowing users to pay transaction fees in USDT or USDC instead of needing a separate TRX balance — a meaningful retail friction reduction
Tron Inc. Nasdaq listing and corporate treasury accumulation of over 681 million TRX
Integration with the B.AI agent platform, embedding TRX and TRC-20 USDT into the emerging AI-agent payment economy
TRX did not 10x. It did not need to. It delivered a steady 35% on top of a portfolio of higher-beta names — exactly the role a disciplined ranking system assigns to a fundamentally backed asset.
5. Monero (XMR) — −1.41%
The only losing position in the basket, and worth examining honestly.
Monero was the other major privacy coin in the cycle, but the institutional flow concentrated almost entirely into ZEC, where ETF filings and a public Naval endorsement created a coordination point that XMR — without any pending U.S. ETF structure and with persistent exchange-delisting headwinds — could not match. XMR traded at $330 in October 2025 and finished the tracking period essentially flat to mildly down.
This is what risk management actually looks like. No ranking system gets every pick right. The BullsEye system surfaced XMR alongside ZEC because the privacy thematic was real — and the ranking captured ZEC's outsized move. The portfolio's structure absorbed the XMR drawdown without breaking the thesis.
A −1.41% position inside a basket that averaged +191% is a feature of disciplined diversification, not a flaw.
The Setup In One Sentence
Two equal-weight baskets, ten total names, zero active rotation, no leverage — and a combined return that turned $10,000 into $46,434 in twelve months.
That is the kind of pattern GrowthTech.ai's market intelligence engine is purpose-built to find before the crowd does.
What GrowthTech.ai Members Say
Browse any growthtech.ai review and a theme emerges:
"The platform surfaces names I'd never find scrolling financial Twitter or watching CNBC."
CELC, IREN, and ACMR are exactly those kinds of names. They do not trend on Reddit. They do not lead pre-market briefings on CNBC. But subscribers who saw the rankings early were positioned long before the consensus story arrived.
The crypto half tells the same story. ZEC was a forgotten privacy coin until it ran 700%. HYPE was a niche DEX token until institutions started filing ETFs. The BullsEye system flagged both before the narrative consolidated.
What's Ranked #1 Right Now?
These ten names already ran. The combined basket already turned $10,000 into $46,434.
But the BullsEye Market Intelligence System is scanning thousands of equities and digital assets every single day, across six different time horizons, looking for the next setup that fits this pattern at the earliest possible stage.
The current top-ranked picks — both stock and crypto — are live inside the platform right now.
Enhanced Market Intelligence
Finding asymmetric market opportunities is what GrowthTech.ai is built for. The platform does not tell you what to do — it tells you where to look. Our analyst team verifies the AI's outputs and overlays the data with experienced human judgment, giving subscribers a level of enhanced market intelligence that simply is not available anywhere else at this price point.
If you would like the AI advantage working for you, you can subscribe today.
Life is better when you can be bullish.
Sources:
Celcuity Inc. Q1 2026 Financial Results and Corporate Update, May 2026
Celcuity Inc. Form 8-K — Phase 3 VIKTORIA-1 PIK3CA-Mutant Cohort Topline Results, May 1, 2026
Micron Technology Q1 FY2026 and Q2 FY2026 Press Releases and analyst notes (Wedbush, BofA, Citi), 2025–2026
IREN Limited Q3 FY2026 Earnings Presentation, May 7, 2026
IREN Limited / NVIDIA Strategic Partnership Announcement, May 2026
IREN Limited / Microsoft $9.7 Billion Cloud Infrastructure Agreement, November 2025
ACM Research Q1 2026 Earnings Release and Form 10-Q, May 2026
Twilio Inc. Q1 2026 Earnings Release and Investor Letter, April 30, 2026
Zcash community disclosures, Multicoin Capital public commentary, Grayscale ETF filings, 2025–2026
Hyperliquid platform data, S&P Dow Jones Indices licensing announcement, Grayscale HYPE ETF filing, March 2026
TRON network data (CoinMarketCap, CryptoSlate), Canary Capital ETF filings, SEC case resolution, 2025–2026
Historical price data for NASDAQ, NYSE, and major crypto exchanges, May 22, 2025 – May 22, 2026
Past performance is not indicative of future results. This article is for informational and educational purposes only and does not constitute financial or investment advice. GrowthTech.ai does not provide individual financial or investment advice and does not act as a personal financial advisor. Always conduct your own due diligence and consult a qualified financial advisor before making any investment decision.
Comments